News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Boyds has added a consultant pharmaceutical physician, Susan Tansey, to its team.
Tansey joins Boyds from Iqvia where she was vice president and global head of therapeutic strategy. A pediatrician specializing in respiratory pediatrics and neonatology, she has more than 20 years of experience in rare disease clinical trials.
She also has worked at Premier Research, the UK National Institute of Health Research, Clinical Research Network, and TMC Pharma Services, and holds the Membership of the Royal Colleges of Physicians (MRCPUK) qualification and has a Certificate of Completion of Specialist Training (CCST) in Pharmaceutical Medicine.
“I am looking forward to the opportunity to expand my knowledge of the new technologies coming through in the rare disease field such as gene therapy and stem cell research,” she told us.
“In addition I look forward to working with the experienced regulatory team at Boyds to assist companies with their pediatric drug development and in navigating the necessary regulatory requirements.”